aztreonam has been researched along with Biliary Cirrhosis in 1 studies
Aztreonam: A monocyclic beta-lactam antibiotic originally isolated from Chromobacterium violaceum. It is resistant to beta-lactamases and is used in gram-negative infections, especially of the meninges, bladder, and kidneys. It may cause a superinfection with gram-positive organisms.
aztreonam : A synthetic monocyclic beta-lactam antibiotic (monobactam), used primarily to treat infections caused by Gram-negative bacteria. It inhibits mucopeptide synthesis in the bacterial cell wall, thereby blocking peptidoglycan crosslinking.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aztreonam was administered as a single, 3-min, 1-g intravenous infusion to 18 subjects, including 6 with biopsy-proven, primary biliary cirrhosis, 6 with biopsy-proven, stable alcoholic cirrhosis, and 6 age- and sex-matched control subjects with normal hepatic functions." | 3.67 | Effects of cirrhosis on kinetics of aztreonam. ( Bartley, EA; Devlin, RG; Hudes, E; MacLeod, CM; Payne, JA; Vernam, K, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MacLeod, CM | 1 |
| Bartley, EA | 1 |
| Payne, JA | 1 |
| Hudes, E | 1 |
| Vernam, K | 1 |
| Devlin, RG | 1 |
1 other study available for aztreonam and Biliary Cirrhosis
| Article | Year |
|---|---|
Effects of cirrhosis on kinetics of aztreonam.
Topics: Anti-Bacterial Agents; Aztreonam; Chromatography, High Pressure Liquid; Humans; Kinetics; Liver Cirr | 1984 |